Federal grants to Gateway Bio Inc
Gateway Bio Inc in Durham, North Carolina received $1.9 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was National Center for Advancing Translational Sciences, with $1.3 million. In fiscal 2025 it was awarded $1.3 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$1.9 million
- Awards3
- Awarded in FY 2025$1.3 million
- Largest award$1.3 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 0 | $0 |
| FY 2023 | 0 | $0 |
| FY 2024 | 1 | $639,172 |
| FY 2025 | 3 | $1.3 million |
Programs that fund Gateway Bio Inc
| Program | Awards | Amount |
|---|---|---|
| National Center for Advancing Translational Sciences | 1 | $1.3 million |
| Allergy and Infectious Diseases Research | 2 | $617,520 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $1.9 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Scale-up and toxicity studies of poegma-uricase - project summary the goal of this phase II sbir is to continue development of gateway bio’s proprietary alternative for poly(ethylene glycol) (PEG) for use as a conjugate to stabilize and increase the circulation half-life of biological therapeutics. | National Center for Advancing Translational Sciences | August 21, 2024 | $1.3 million |
| Next generation stealth lipid for the delivery of mrna - project summary this proposal will develop a lipid nanoparticle (LNP) with a proprietary polyethylene glycol (PEG) alternative as a new peg-free lnp for the delivery of mrna payloads. This proposal is motivated by increasing concerns surroundi | Allergy and Infectious Diseases Research | September 23, 2025 | $314,347 |
| Novel stealth lipid for use in HIV mper vaccine - project summary a critical roadblock to HIV vaccine development is the inability to induce b cell lineages of broadly neutralizing antibodies (BNABS) in humans. The hvtn 133 clinical trial (NCT03934541) utilized a peptide-liposome immunogen targeting | Allergy and Infectious Diseases Research | August 29, 2025 | $303,173 |
Questions people ask
How much federal grant money does Gateway Bio Inc get?
$1.9 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Gateway Bio Inc the most?
The Department of Health and Human Services, with $1.9 million in 3 awards.
What is Gateway Bio Inc's largest federal grant?
$1.3 million under National Center for Advancing Translational Sciences, with its first action in the period on August 21, 2024. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Gateway Bio Inc?
Its largest are National Center for Advancing Translational Sciences and Allergy and Infectious Diseases Research.
Other grant recipients in Durham
- Duke University
- Family Health International
- North Carolina Central University
- Housing Authority of the City of Durham
- Rho Federal Systems Division Inc
- City of Durham
- Families & Communities Rising, Inc.
- Lincoln Community Health Center Incorporated
Largest federal grant recipients in North Carolina · Federal grants in North Carolina